2 drugs already on the market show promise against tuberculosis

A two-drug combination is one of the most promising advances in decades for the treatment of tuberculosis (TB) -- a disease that kills 2 million people annually -- a scientist reported today at the 243rd National Meeting & Exposition of the American Chemical Society (ACS). The treatment, which combines two medications already approved by the US Food and Drug Administration (FDA), delivers a knockout punch to forms of TB that shrug off other antibiotics. Read more